Oridonin inhibits gefitinib-resistant lung cancer cells by suppressing EGFR/ERK/MMP-12 and CIP2A/Akt signaling pathways
2016 · International Journal of Oncology · 62 citations
https://doi.org/10.3892/ijo.2016.3488
C
Chao Duan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
189
Papers
2.4K
Citations
24
h-index
41
i10-index
Chao Duan is an academic researcher from Hubei University of Medicine. The author has contributed to research in topics: Neuroblastoma Research and Treatments & Advanced Fiber Optic Sensors & Lung Cancer Research Studies. The author has an h-index of 24, co-authored 161 publications.
ORCID: 0000-0003-4423-2156Papers by this author
worksWhole exome sequencing reveals novel somatic alterations in neuroblastoma patients with chemotherapy
2018 · Cancer Cell International · 50 citations
https://doi.org/10.1186/s12935-018-0521-3
Multidirectional characterization of cellular composition and spatial architecture in human multiple primary lung cancers
2023 · Cell Death and Disease · 31 citations
https://doi.org/10.1038/s41419-023-05992-w
Increased plasma concentration of cell-free DNA precedes disease recurrence in children with high-risk neuroblastoma
2020 · BMC Cancer · 22 citations
https://doi.org/10.1186/s12885-020-6562-8
A high-throughput drug combination screen identifies an anti-glioma synergism between TH588 and PI3K inhibitors
2020 · Cancer Cell International · 13 citations
https://doi.org/10.1186/s12935-020-01427-0
Clinical characteristics of malignant germ cell tumors in adolescents: A multicenter 10‐year retrospective study in Beijing
2023 · Cancer Innovation · 5 citations
https://doi.org/10.1002/cai2.87
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat